These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10676757)

  • 1. Neurotoxicants and the cytoskeleton.
    Graham DG
    Curr Opin Neurol; 1999 Dec; 12(6):733-7. PubMed ID: 10676757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper.
    LoPachin RM; Lehning EJ
    Neurotoxicology; 1997; 18(1):7-22. PubMed ID: 9215980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.
    Llorens J
    J Intern Med; 2013 May; 273(5):478-89. PubMed ID: 23331301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings.
    Anthony DC; Boekelheide K; Graham DG
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):362-71. PubMed ID: 6686353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy.
    Graham DG; Szakál-Quin G; Priest JW; Anthony DC
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4979-82. PubMed ID: 6589640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport.
    Monaco S; Wongmongkolrit T; Shearson CM; Patton A; Schaetzle B; Autilio-Gambetti L; Gambetti P; Sayre LM
    Brain Res; 1990 Jun; 519(1-2):73-81. PubMed ID: 2118823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurotoxins 2,5-hexanedione and acrylamide promote aggregation of intermediate filaments in cultured fibroblasts.
    Durham HD; Pena SD; Carpenter S
    Muscle Nerve; 1983; 6(9):631-7. PubMed ID: 6361548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent crosslinking of neurofilaments in the pathogenesis of n-hexane neuropathy.
    Graham DG; Anthony DC; Szakál-Quin G; Gottfried MR; Boekelheide K
    Neurotoxicology; 1985; 6(4):55-63. PubMed ID: 3937075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: video-enhanced differential interference microscopy in peripheral nervous system axons.
    Stone JD; Peterson AP; Eyer J; Oblak TG; Sickles DW
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):50-8. PubMed ID: 10558923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy.
    Graham DG; Anthony DC; Boekelheide K
    Neurobehav Toxicol Teratol; 1982; 4(6):629-34. PubMed ID: 7170020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic studies of hexane and carbon disulfide neurotoxicity.
    Graham DG; Amarnath V; Valentine WM; Pyle SJ; Anthony DC
    Crit Rev Toxicol; 1995; 25(2):91-112. PubMed ID: 7612176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-Diketone central neuropathy: quantitative analyses of cytoskeletal components in myelinated axons of the rat rubrospinal tract.
    Lopachin RM; Jortner BS; Reid ML; Monir A
    Neurotoxicology; 2005 Dec; 26(6):1021-30. PubMed ID: 15964632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeletal disorganization induced by local application of beta, beta'-iminodipropionitrile and 2,5-hexanedione.
    Griffin JW; Fahnestock KE; Price DL; Cork LC
    Ann Neurol; 1983 Jul; 14(1):55-61. PubMed ID: 6684411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.
    Tshala-Katumbay D; Monterroso V; Kayton R; Lasarev M; Sabri M; Spencer P
    Toxicol Sci; 2009 Feb; 107(2):482-9. PubMed ID: 19033394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic neuropathies: Mechanistic insights based on a chemical perspective.
    LoPachin RM; Gavin T
    Neurosci Lett; 2015 Jun; 596():78-83. PubMed ID: 25218479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport: pulse labeling in CNS neurons.
    Stone JD; Peterson AP; Eyer J; Sickles DW
    Neurotoxicology; 2000 Aug; 21(4):447-57. PubMed ID: 11022855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon disulfide axonopathy. Another experimental model characterized by acceleration of neurofilament transport and distinct changes of axonal size.
    Pappolla M; Penton R; Weiss HS; Miller CH; Sahenk Z; Autilio-Gambetti L; Gambetti P
    Brain Res; 1987 Oct; 424(2):272-80. PubMed ID: 2445451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilamentous swellings and axonal atrophy are of unclear significance to diketone toxicity: commentary on forum position paper.
    Sickles DW
    Neurotoxicology; 1997; 18(1):33-6; discussion 37-40. PubMed ID: 9215985
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 2,5-hexanedione on calpain-mediated degradation of human neurofilaments in vitro.
    Heijink E; Scholten SW; Bolhuis PA; de Wolff FA
    Chem Biol Interact; 2000 Dec; 129(3):231-47. PubMed ID: 11137063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy.
    Kim MS; Sabri MI; Miller VH; Kayton RJ; Dixon DA; Spencer PS
    Toxicol Appl Pharmacol; 2001 Dec; 177(2):121-31. PubMed ID: 11740911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.